Sign In
Buy JAGX
$2.92
-0.300 (-9.32%)
At Close: Jun 03, 2026
Jaguar Health's stock drops after results supporting ‘paramount' trial have not been received yet
09:46am, Tuesday, 21'st Nov 2023
Shares of Jaguar Health Inc. JAGX were mauled for a 21.2% loss in morning trading Tuesday, after the drug maker said it has not yet received data supporting the Phase 3 trial of its treatment of diarr
Jaguar Health, Inc. (JAGX) Q3 2023 Earnings Call Transcript
12:03pm, Tuesday, 14'th Nov 2023
Jaguar Health, Inc. (JAGX) Q3 2023 Earnings Call Transcript
Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
08:30am, Wednesday, 08'th Nov 2023
Click here to register for November 14 investor webcast Company plans to file its Earnings Report on November 14, 2023 on Form 10-Q for the quarter ended September 30, 2023 REMINDER: Jaguar to host vi
Jaguar Health to Present November 1st at Emerging Growth Conference
08:30am, Thursday, 26'th Oct 2023
Individual and institutional investors as well as advisors, analysts, and members of the financial media are invited to attend Jaguar's real-time interactive presentation SAN FRANCISCO, CA / ACCESSWIR
Top line results of this pivotal trial expected before Thanksgiving More than 1 million cancer patients in the US receive chemotherapy or radiation each year, according to the CDC, and cancer patients
Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
08:30am, Thursday, 12'th Oct 2023
Top line results expected in the coming weeks for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea Jaguar is supporting investigator-initiat
Top line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea Jaguar is supporting investigator-initiated
Filament Health's Magdalena Biosciences JV with Jaguar Health completes import of coca leaf from Peru
07:00am, Wednesday, 20'th Sep 2023
Filament Health Corp (OTCQB:FLHLF) told investors that its Magdalena Biosciences joint venture (JV) with Jaguar Health has completed an import of coca leaf to Filament's Metro Vancouver research and d
Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
08:30am, Thursday, 14'th Sep 2023
Click here to access webcast replay Top line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea Jaguar
Napo Pharmaceuticals, a Jaguar family company, reported completion August 17 of last patient last visit for its pivotal Phase 3 OnTarget trial of crofelemer for preventive treatment of cancer therapy-
Jaguar Health, Inc. (JAGX) Q2 2023 Earnings Call Transcript
10:42am, Monday, 14'th Aug 2023
Jaguar Health, Inc. (NASDAQ:JAGX ) Q2 2023 Earnings Conference Call August 14, 2023 8:30 AM ET Company Participants Lisa Conte - President and Chief Executive Officer Carol Lizak - Chief Financial Off
Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
08:30am, Thursday, 10'th Aug 2023
Click here to register for webcast Company plans to file its Earnings Report on August 14, 2023 on Form 10-Q for the quarter ended June 30, 2023 SAN FRANCISCO, CA / ACCESSWIRE / August 10, 2023 / Jagu
Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
08:30am, Thursday, 03'rd Aug 2023
SAN FRANCISCO, CA / ACCESSWIRE / August 3, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, is presenting at an invitation-only lunch
Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference
08:30am, Thursday, 15'th Jun 2023
Reminder: Ladenburg Thalmann to host virtual discussion June 22, 2023 at 1:00 PM EDT with Jaguar CEO and leading patient advocates on impact of cancer therapy-related diarrhea on patients & importance
Jaguar Animal Health, Inc. (JAGX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
11:02am, Tuesday, 13'th Jun 2023
After losing some value lately, a hammer chart pattern has been formed for Jaguar Animal Health, Inc. (JAGX), indicating that the stock has found support. This, combined with an upward trend in earnin
